Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

Similar articles for PubMed (Select 23535847)

1.

Metastasis: ADORA(2B)tion.

McCarthy N.

Nat Rev Cancer. 2013 May;13(5):294-5. doi: 10.1038/nrc3508. Epub 2013 Mar 28. No abstract available.

PMID:
23535847
2.

Adenosine A(3) receptor mediated coronary vasodilation in the rat heart: changes that occur with maturation.

Jenner TL, Rose'meyer RB.

Mech Ageing Dev. 2006 Mar;127(3):264-73. Epub 2005 Nov 22.

PMID:
16309733
3.

Adenosine inhibition of lipopolysaccharide-induced interleukin-6 secretion by the osteoblastic cell line MG-63.

Russell JM, Stephenson GS, Yellowley CE, Benton HP.

Calcif Tissue Int. 2007 Oct;81(4):316-26. Epub 2007 Aug 20.

PMID:
17705048
4.

Differential expression of adenosine A3 receptors controls adenosine A2A receptor-mediated inhibition of TLR responses in microglia.

van der Putten C, Zuiderwijk-Sick EA, van Straalen L, de Geus ED, Boven LA, Kondova I, IJzerman AP, Bajramovic JJ.

J Immunol. 2009 Jun 15;182(12):7603-12. doi: 10.4049/jimmunol.0803383.

5.

The measurement of adenosine and estrogen receptor expression in rat brains following ovariectomy using quantitative PCR analysis.

Rose'Meyer RB, Mellick AS, Garnham BG, Harrison GJ, Massa HM, Griffiths LR.

Brain Res Brain Res Protoc. 2003 Mar;11(1):9-18.

PMID:
12697258
6.

[Expression of survivin and PCNA in lung cancer cells induced by Gejiu mineral powder].

Liang R, Jin K, Wang Z, Zhao Z, Wang F, Gao Q, Ruan Y.

Zhongguo Fei Ai Za Zhi. 2007 Apr 20;10(2):83-7. doi: 10.3779/j.issn.1009-3419.2007.02.01. Chinese.

7.
8.

Enhanced visible-light-induced photocatalytic disinfection of E. coli by carbon-sensitized nitrogen-doped titanium oxide.

Li Q, Xie R, Li YW, Mintz EA, Shang JK.

Environ Sci Technol. 2007 Jul 15;41(14):5050-6.

PMID:
17711222
9.

Choroidal metastasis from medullary thyroid carcinoma in multiple endocrine neoplasia.

Shields JA, Shields CL, Perez N.

Am J Ophthalmol. 2002 Oct;134(4):607-9.

PMID:
12383823
10.

A retrospective analysis of antidepressant poisonings in the emergency department: 11-year experience.

Unverir P, Atilla R, Karcioglu O, Topacoglu H, Demiral Y, Tuncok Y.

Hum Exp Toxicol. 2006 Oct;25(10):605-12.

PMID:
17165627
11.

Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel.

Huang SF, Kim SJ, Lee AT, Karashima T, Bucana C, Kedar D, Sweeney P, Mian B, Fan D, Shepherd D, Fidler IJ, Dinney CP, Killion JJ.

Cancer Res. 2002 Oct 15;62(20):5720-6.

12.

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH.

J Clin Oncol. 1996 Jan;14(1):7-17.

PMID:
8558223
13.

Adenosine A(2b) receptor is highly expressed in human hepatocellular carcinoma.

Xiang HJ, Liu ZC, Wang DS, Chen Y, Yang YL, Dou KF.

Hepatol Res. 2006 Sep;36(1):56-60. Epub 2006 Jul 17.

PMID:
16844405
14.

Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.

Gershenwald JE, Sumner W, Calderone T, Wang Z, Huang S, Bar-Eli M.

Oncogene. 2001 Jun 7;20(26):3363-75.

15.

Effects of aging and ischemia on adenosine receptor transcription in mouse myocardium.

Ashton KJ, Nilsson U, Willems L, Holmgren K, Headrick JP.

Biochem Biophys Res Commun. 2003 Dec 12;312(2):367-72.

PMID:
14637147
16.

Efficacy, safety, and risk-benefit analysis of adjuvant interferon alfa-2b in melanoma.

Kirkwood JM, Resnick GD, Cole BF.

Semin Oncol. 1997 Feb;24(1 Suppl 4):S16-23.

PMID:
9122729
17.

Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma.

Eggermont AM, Suciu S, Testori A, Santinami M, Kruit WH, Marsden J, Punt CJ, Salès F, Dummer R, Robert C, Schadendorf D, Patel PM, de Schaetzen G, Spatz A, Keilholz U.

J Clin Oncol. 2012 Nov 1;30(31):3810-8. doi: 10.1200/JCO.2011.41.3799. Epub 2012 Sep 24.

18.

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.

Eggermont AM, Suciu S, Santinami M, Testori A, Kruit WH, Marsden J, Punt CJ, Salès F, Gore M, Mackie R, Kusic Z, Dummer R, Hauschild A, Musat E, Spatz A, Keilholz U; EORTC Melanoma Group.

Lancet. 2008 Jul 12;372(9633):117-26. doi: 10.1016/S0140-6736(08)61033-8.

PMID:
18620949
19.

Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma.

Mitchell MS, Abrams J, Thompson JA, Kashani-Sabet M, DeConti RC, Hwu WJ, Atkins MB, Whitman E, Ernstoff MS, Haluska FG, Jakowatz JG, Das Gupta TK, Richards JM, Samlowski WE, Costanzi JJ, Aronson FR, Deisseroth AB, Dudek AZ, Jones VE.

J Clin Oncol. 2007 May 20;25(15):2078-85.

20.

Interferon Alfa-2b or not 2b? Significant differences exist in the decision-making process between melanoma patients who accept or decline high-dose adjuvant interferon Alfa-2b treatment.

Bramlette TB, Lawson DH, Washington CV, Veledar E, Johns BR, Brisman SF, Abramova L, Chen SC.

Dermatol Surg. 2007 Jan;33(1):11-6.

PMID:
17214673
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk